Gerresheimer AG (GXI) PT Set at €65.00 by Kepler Capital Markets
Gerresheimer AG (ETR:GXI) has been assigned a €65.00 ($76.47) price target by research analysts at Kepler Capital Markets in a report released on Friday. The brokerage presently has a “sell” rating on the stock. Kepler Capital Markets’ price target would indicate a potential downside of 2.45% from the company’s previous close.
A number of other equities analysts have also recently issued reports on the company. Commerzbank Ag set a €77.00 ($90.59) price objective on Gerresheimer AG and gave the stock a “buy” rating in a report on Monday, October 23rd. HSBC Holdings plc set a €65.00 ($76.47) price objective on Gerresheimer AG and gave the stock a “neutral” rating in a report on Tuesday, October 17th. Deutsche Bank AG set a €64.00 ($75.29) price objective on Gerresheimer AG and gave the stock a “neutral” rating in a report on Thursday, October 12th. Goldman Sachs Group, Inc. (The) set a €69.50 ($81.76) target price on Gerresheimer AG and gave the company a “neutral” rating in a research note on Thursday, October 12th. Finally, Independent Research GmbH set a €68.00 ($80.00) target price on Gerresheimer AG and gave the company a “neutral” rating in a research note on Wednesday, October 11th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of €72.64 ($85.46).
Gerresheimer AG Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with Analyst Ratings Network's FREE daily email newsletter.